Copeland Capital Management LLC Trims Stake in Encompass Health Corporation $EHC

Key Points

• Copeland Capital Management LLC reduced its stake in Encompass Health Corporation (NYSE:EHC) by 28.1%, now holding 909,231 shares valued at approximately $111.5 million.
• Several institutional investors increased their holdings in Encompass Health, notably T. Rowe Price, which boosted its stake by 25.6% to over 2 million shares.
• Encompass Health's quarterly earnings beat analyst estimates, reporting an EPS of $1.40 against predictions of $1.20 and achieving a revenue of $1.46 billion, up 12% year-over-year.

Copeland Capital Management LLC cut its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 28.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 909,231 shares of the company's stock after selling 354,540 shares during the period. Encompass Health accounts for 2.3% of Copeland Capital Management LLC's investment portfolio, making the stock its 2nd largest holding. Copeland Capital Management LLC owned about 0.90% of Encompass Health worth $111,499,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in EHC. Congress Asset Management Co. bought a new stake in Encompass Health in the second quarter valued at approximately $92,691,000. Nuveen LLC bought a new stake in Encompass Health in the first quarter valued at approximately $50,665,000. T. Rowe Price Investment Management Inc. boosted its holdings in Encompass Health by 25.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company's stock valued at $210,756,000 after acquiring an additional 424,691 shares during the last quarter. Strs Ohio bought a new stake in Encompass Health in the first quarter valued at approximately $34,364,000. Finally, American Century Companies Inc. boosted its holdings in Encompass Health by 78.6% in the first quarter. American Century Companies Inc. now owns 723,169 shares of the company's stock valued at $73,243,000 after acquiring an additional 318,251 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on EHC shares. UBS Group increased their price target on Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Thursday. Bank of America increased their price target on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a report on Wednesday, September 10th. KeyCorp increased their price target on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a report on Tuesday, September 16th. Wall Street Zen cut Encompass Health from a "strong-buy" rating to a "buy" rating in a report on Friday, June 6th. Finally, Truist Financial increased their price target on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $139.86.

Insider Buying and Selling

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares in the company, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.00% of the company's stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $123.58 on Friday. The firm has a market capitalization of $12.45 billion, a PE ratio of 24.18, a price-to-earnings-growth ratio of 2.18 and a beta of 0.93. The firm has a fifty day simple moving average of $120.94 and a two-hundred day simple moving average of $115.37. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.86.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. Encompass Health's quarterly revenue was up 12.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This is a boost from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date is Wednesday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.6%. Encompass Health's dividend payout ratio (DPR) is presently 14.87%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.